Erik Atkisson
Compliance Officer chez RAIN ONCOLOGY INC.
Fortune : 1 001 $ au 31/03/2024
Profil
Erik Atkisson is currently the General Counsel & Chief Compliance Officer at Rain Oncology, Inc. Prior to this, he was the Chief Compliance Officer at Cytokinetics, Inc. He also served as the Secretary & General Counsel at Eiger BioPharmaceuticals, Inc. from 2021 to 2023.
Mr. Atkisson received his undergraduate degree from Harvard University, his graduate degree from The University of Edinburgh, and his law degree from Georgetown University Law Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/01/2023 | 200 ( 0,01% ) | 1 001 $ | 31/03/2024 |
Postes actifs de Erik Atkisson
| Sociétés | Poste | Début |
|---|---|---|
| RAIN ONCOLOGY INC. | Compliance Officer | - |
Anciens postes connus de Erik Atkisson
| Sociétés | Poste | Fin |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Compliance Officer | 13/04/2023 |
| CYTOKINETICS, INCORPORATED | Compliance Officer | - |
Formation de Erik Atkisson
| Harvard University | Undergraduate Degree |
| The University of Edinburgh | Graduate Degree |
| Georgetown University Law Center | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
